Benitec Biopharma BNTC
NASDAQ BNTC
$9.58 -0.42 (-4.20%)
At close: Oct 1, 2026 · 4:00 PM EDT

Benitec Biopharma (BNTC) Net Equity Issued and Repurchased (2019 - 2021)

Updated

Benitec Biopharma (BNTC) posted Net Equity Issued and Repurchased of $104.5 million for FY2026 (year ended Jun 30, 2026), up 243.1% from $30.46 million in FY2025.

Analysis

Benitec Biopharma (BNTC) Net Equity Issued and Repurchased (2019 - 2021) Analysis & Trends

Since FY2020, Benitec Biopharma has reported Net Equity Issued and Repurchased for 5 fiscal years.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 32.3% (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual Net Equity Issued and Repurchased in data going back to FY2020.
  • Business Quant data shows BNTC's Net Equity Issued and Repurchased at $30.46 million in FY2025 and $17.88 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Benitec Biopharma 465.58 Mn 465.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 14.25 Mn
Mar 31, 2021 3,000.00
Sep 30, 2019 2.25 Mn
API Access

Benitec Biopharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BNTC&period=max&api_key=YOUR_API_KEY